CBF in Pediatric Brain Death: Diagnostic Yield From First Versus Any Study
| Study . | Total # of Pts in Study . | CBF#1: % Patients With Absent CBF* . | % Patients With Absent CBF on Any Study** . | % Pts With No CBF on f/u Study When First Study Had Shown No CBF . | % Pt With No CBF on Later Study When First Study Had CBF Present . |
|---|---|---|---|---|---|
| Shimizu et al, 200066 | 228 | 100% (27/27) | 100% (27/27) | NA | NA |
| Ruiz-Garcia et al, 200060 | 125 | 92% (83/90) | 92% (83/90) | NA | NA |
| Drake et al, 198655 | 61 | 68% (32/47) | 81% (38/47) | 100% (17/17) | 40% (6/15) |
| Parker et al, 199536 | 60 | 87% (26/30) | 87% (26/30) | NA | NA |
| Coker et al, 198659 | 55 | 100% (55/55) | 100% (55/55) | NA | NA |
| Ashwal, 199354 | 52 | 86% (19/22) | 86% (19/22) | NA | NA |
| Ahmann et al, 198767 | 32 | 83% (6/6) | 83% (6/6) | NA | NA |
| Ashwal &Schneider, 198965 | 18 | 65% (11/17) | 65% (11/17) | 71% (5/7) | 0% (0/3) |
| Holzman et al, 198362 | 18 | 39% (7/18) | 44% (8/18) | 100% (2/2) | 9% (1/11) |
| Ashwal et al, 197758 | 15 | 100% (11/11) | 100% (11/11) | NA | NA |
| Schwartz et al, 198468 | 9 | 100% (9/9) | 100% (9/9) | NA | NA |
| Okuyaz et al, 200464 | 8 | 75% (6/8) | 100% (8/8) | NA | 100% (2/2) |
| Total | 681 | 86% (292/340) | 89% (301/340) | 92% (24/26) | 26% (9/34) |
| Study . | Total # of Pts in Study . | CBF#1: % Patients With Absent CBF* . | % Patients With Absent CBF on Any Study** . | % Pts With No CBF on f/u Study When First Study Had Shown No CBF . | % Pt With No CBF on Later Study When First Study Had CBF Present . |
|---|---|---|---|---|---|
| Shimizu et al, 200066 | 228 | 100% (27/27) | 100% (27/27) | NA | NA |
| Ruiz-Garcia et al, 200060 | 125 | 92% (83/90) | 92% (83/90) | NA | NA |
| Drake et al, 198655 | 61 | 68% (32/47) | 81% (38/47) | 100% (17/17) | 40% (6/15) |
| Parker et al, 199536 | 60 | 87% (26/30) | 87% (26/30) | NA | NA |
| Coker et al, 198659 | 55 | 100% (55/55) | 100% (55/55) | NA | NA |
| Ashwal, 199354 | 52 | 86% (19/22) | 86% (19/22) | NA | NA |
| Ahmann et al, 198767 | 32 | 83% (6/6) | 83% (6/6) | NA | NA |
| Ashwal &Schneider, 198965 | 18 | 65% (11/17) | 65% (11/17) | 71% (5/7) | 0% (0/3) |
| Holzman et al, 198362 | 18 | 39% (7/18) | 44% (8/18) | 100% (2/2) | 9% (1/11) |
| Ashwal et al, 197758 | 15 | 100% (11/11) | 100% (11/11) | NA | NA |
| Schwartz et al, 198468 | 9 | 100% (9/9) | 100% (9/9) | NA | NA |
| Okuyaz et al, 200464 | 8 | 75% (6/8) | 100% (8/8) | NA | 100% (2/2) |
| Total | 681 | 86% (292/340) | 89% (301/340) | 92% (24/26) | 26% (9/34) |
# pts with no CBF on first study/# pts with first CBF study.
# pts with no CBF on any study/# pts with any CBF.
CBF Cerebral blood flow.